Hemodynamic analysis of post-reperfusion syndrome and the effect of preventing this syndrome using thromboxane A2 synthetase inhibitor (OKY-046) in swine liver transplantation
Ishine, N.; Yagi, T.; Ishikawa, T.; Sasaki, H.; Nakagawa, K.; Tanaka, N.
Transplantation Proceedings 29(1-2): 378-381
1997
ISSN/ISBN: 0041-1345 PMID: 9123045 Document Number: 479444
Document emailed within 1 workday
Related Documents
Pérez-Cerdá, F.; del Campo, I.; Cortés, M.; Martínez de Guereñu, A.; Dávila, P. 1997: The post-reperfusion syndrome in liver transplantation Revista Espanola de Anestesiologia y Reanimacion 44(4): 162-164Niwa, T.; Maeda, K.; Shibata, M.; Yamada, K. 1988: Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome Clinical Nephrology 30(5): 276-281
Nakayama, D.; Ikeda, T. 1988: Effect of OKY-046, a thromboxane synthetase inhibitor, on renal thromboxane synthesis in spontaneously hypertensive rat Nihon Jinzo Gakkai Shi 30(1): 79-84
Ishine, N.; Tanaka, N.; Yagi, T.; Oishi, M.; Ishikawa, T.; Orita, K. 1996: Postreperfusion syndrome in swine liver transplantation: comparison between orthotopic liver transplantation and total hepatectomy with portacaval shunt using aortic graft Transplantation Proceedings 28(3): 1756-1758
Chiabrando, C.; Broggini, M.; Castelli, M.G.; Cozzi, E.; Castagnoli, M.N.; Donelli, M.G.; Garattini, S.; Giavazzi, R.; Fanelli, R. 1987: Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor Cancer Research 47(4): 988-991
Ogawa, T.; Hieda, N.; Sugiyama, S.; Toki, Y.; Ito, T.; Ogawa, K.; Satake, T.; Ozawa, T. 1988: Effect of a novel thromboxane A2 synthetase inhibitor on ischemia-induced mitochondrial dysfunction in canine hearts Arzneimittel-Forschung 38(2): 228-230
Sills, T.; Heptinstall, S. 1986: Effects of a thromboxane synthetase inhibitor and a cAMP phosphodiesterase inhibitor, singly and in combination, on platelet behaviour Thrombosis and Haemostasis 55(3): 305-308
Nizankowski, R.; Krzanowski, M.; Musiał, J.; Szczeklik, A. 1991: Effect of thromboxane A2 synthetase inhibitor and prostacyclin analogue on arterial blood pressure, fibrinolysis and platelet function in patients with hypertension Polski Tygodnik Lekarski 46(1-3): 18-21
Basevich, V.V.; Mevkh, A.T.; Varfolomeev, S.D. 1984: Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets Biokhimiia 49(9): 1538-1545
Machida, K.; Takagi, K.; Horiba, M. 1996: Thromboxane A2 synthetase inhibitor in asthma therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 54(11): 3034-3039
Smeesters, C.; Chaland, P.; Giroux, L.; Moutquin, J.M.; Etienne, P.; Douglas, F.; Corman, J.; St-Louis, G.; Daloze, P. 1988: Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor Transplantation Proceedings 20(2 Suppl. 2): 663-669
Okamoto, S.; Yonekawa, Y.; Handa, H.; Handa, Y.; Uemura, Y.; Yano, I.; Toyoshima, M.; Iwatsuji, K.; Teraura, T.; Yamagata, S. 1986: Treatment of occlusive cerebrovascular disease with a selective thromboxane A2 synthetase inhibitor Nihon Geka Hokan. Archiv für Japanische Chirurgie 55(1): 251-259
Fomsgaard, J.S.; Kim, Y.D.; Burke, T.A.; Viswanathan, T.; Schaffer, A.V.; Peppard, J.; Douglas, F.L.; Danchak, M.; Myers, A.K. 1992: Comparison of thromboxane synthetase inhibitor and methylprednisolone effects on protamine responses in dogs Anesthesia and Analgesia 74(1): 38-43
Ohsugi, S. 1986: Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046 Nihon Geka Hokan. Archiv für Japanische Chirurgie 55(2): 297-305
Grauer, G.F.; Frisbie, D.D.; Longhofer, S.L.; Cooley, A.J. 1992: Effects of a thromboxane synthetase inhibitor on established immune complex glomerulonephritis in dogs American Journal of Veterinary Research 53(5): 808-813
Ennis, C.; Granger, S.E.; Middlefell, V.C.; Philpot, M.E.; Shepperson, N.B. 1989: Pharmacologic effects of Wy 27569: a combined calcium channel blocker and thromboxane synthetase inhibitor Journal of Cardiovascular Pharmacology 13(4): 511-519
Murayama, K.; Kasai, H.; Adachi, T.; Utsunomiya, O.; Ouchi, H. 1983: Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs Nihon Sanka Fujinka Gakkai Zasshi 35(3): 344-350
Marín-Gómez, L.M.; Álamo-Martínez, J.é M.ía.; Suárez-Artacho, G.; Ramírez-Santos, J.é; Bernal-Bellido, C.; Barrera-Pulido, L.; Serrano-Díaz-Canedo, J.; Padillo-Ruiz, F.J.; Gómez-Bravo, M.Án. 2015: Is the sinusoidal obstructive syndrome post-liver transplantation a pathologic entity with a multifactorial etiology? Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 107(4): 235-238
Simpson, P.J.; Smith, C.B.; Rosenthal, G.; Lucchesi, B.R. 1986: Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury Journal of Pharmacology and Experimental Therapeutics 238(2): 497-501
Shimizu, K.; Kobayashi, J.; Iwanaga, T.; Kuratomi, Y.; Kitamura, S. 1989: Effects of thromboxane A2 synthetase inhibitor, DP-1904 on the action of vasoactive substances in rabbit blood vessel smooth muscle preparations Nihon Kyobu Shikkan Gakkai Zasshi 27(5): 591-596